In-vivo Imaging Market Size & Share, by Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems); Techniques (Radioisotopes, Biomarkers, Luminescent Proteins); End-user (Hospitals, Imaging Centers, Research Organizations); Reagents (Optical Imaging, Nuclear Imaging); Contrast Agents (MRI, Ultrasound, CT) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5231
  • Published Date: Sep 15, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024 - 2036

In-vivo Imaging Market size is poised to reach USD 6 Billion by the end of 2036, growing at a rate of 6% during the forecast period, i.e., 2024 – 2036. In the year 2023, the industry size of in-vivo imaging was USD 3 Billion. The reason behind the growth is impelled by the increasing cases of cancer across the globe. Cancer is the primary cause of death, and in nations with low Human Development Indexes (HDI), the number of new cases is rising rapidly.

In the study of cancer biology as well as in clinical prognosis and treatment, In-vivo imaging has emerged as a crucial tool as it offers one-of-a-kind, cutting-edge capabilities to help with the development of protocols for cancer detection and diagnosis.

According to estimates, by 2040, there will be more than 26 million new instances of cancer annually throughout the world.

The rising trend of precision medicine is believed to fuel the market growth. Precision medicine has helped reduce superfluous, pointless testing and unnecessary hospital admissions and has led to more accurate diagnoses and forecasts of disease risk before any symptoms appear. 

Moreover, precision medicine is an effective method for examining the human body in vivo molecular imaging, which allows for more accurate diagnostics and real-time monitoring.


In-vivo Imaging Market
Get more information on this report: Request Free Sample PDF

In-vivo Imaging Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Popularity of Minimally Invasive Procedures – Patients are becoming more and more familiar with less invasive procedures as they offer them several advantages such as less pain, and shorter hospital stays. In-vivo imaging is a non-invasive method that is becoming a crucial tool for preclinical research and can be utilized in fundamental biomedical research and clinical medicine.
  • Growing Geriatric Population- The elderly population is more prone to various age-related diseases such as cancer, and neurodegenerative disorders, which necessitates the usage of In-vivo imaging techniques for diagnosing and monitoring these conditions. Lately, more than 8% of the world's population, are over 65.

Challenges

  • High Cost of Procedure – In-vivo imaging technologies involve an in-vivo microscope which can easily cost over USD 1 million, which is too expensive in several developing nations. Besides this, cost is one of the main disadvantages of micro-MRI. Systems used for animal imaging, with most systems costing more than USD 1 million.
  • Data Complexity
  • Ethical Concerns associated with Involvement of Animals

In-vivo Imaging Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~6%

Base Year Market Size (2023)

~ USD 3 Billion

Forecast Year Market Size (2036)

~ USD 6 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

In-vivo Imaging Segmentation

Modality (Nuclear Imaging Systems, Optical Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems)

The micro-MRI segment is estimated to hold 21% share of the global in-vivo imaging market in the coming years owing to the growing usage in small animal imaging. In vivo, 3D imaging of microstructure in small animals such as mice and rats is made easier with the use of micro-MRI since small animal models play a crucial role in cardiovascular investigation and help researchers in studying In-vivo molecular pathways in cardiovascular pathology.

Techniques (Biomarkers Based, Luminescent Proteins Based, Radioisotopes Based)

The radioisotopes based segment is set to garner a notable share shortly. Radioisotope-based based In-vivo imaging is widely used in preclinical research to study diseases in living organisms. For instance, positron emission tomography (PET) is an imaging technique that uses radioisotopes to inject a small amount of radioactive glucose into the veins of animals to study metabolic processes and more.

Our in-depth analysis of the global market includes the following segments:

      Modality

  • Optical Imaging Systems
  •  Nuclear Imaging Systems
  • Micro-MRI
  • Micro-Ultrasound
  • Micro-CT
  •  Photoacoustic Imaging Systems
  • Magnetic Particle Imaging Systems

     Techniques

  • Radioisotopes Based
  •  Biomarkers Based
  • Luminescent Proteins Based

     End-User

  • Hospitals and Clinics
  •  Imaging Centers
  •  Research Organizations

     Reagents

  • Optical Imaging Reagents
  •  Nuclear Imaging Reagents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  •  CT Contrast Agents

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

In-vivo Imaging Industry- Regional Synopsis

APAC Market Forecast

In-vivo imaging market in Asia Pacific is predicted to account for the largest share of 46% by 2036 impelled by the increasing spending in healthcare. This has led to the expansion of research & development activities in healthcare technology in the region, which might result in the development of more advanced In-vivo imaging techniques. According to estimates, the predicted cost of healthcare in India in 2020 was more than USD 190 billion.

North American Market Statistics

The North America In-vivo imaging market is estimated to be the second largest, during the forecast timeframe led by the presence of well-established healthcare infrastructure. The American economy's most important sector is the healthcare industry which focuses on cutting costs and enhancing patient outcomes. As a result, the availability of skilled medical professionals and advanced diagnostic techniques including for more precise diagnosis of diseases has increased in the region. This is expected to create huge demand for In-vivo imaging techniques.

Research Nester
In-vivo Imaging Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the In-vivo Imaging Landscape

top-features-companies
    • PerkinElmer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bruker
    • FUJIFILM VisualSonics Inc.
    • Siemens
    • Miltenyi Biotec
    • CMR Naviscan
    • SCANCO Medical AG
    • Aspect Imaging Ltd.
    • Mediso Ltd.
    • LI-COR, Inc.
    • MILabs B.V.
    • MR Solutions
    • Trifoil Imaging
    • Biospace Lab

In-the-news

In The News

  • PerkinElmer Inc. announced to introduce a Vega imaging system that permits scientists to quickly sequentially scan up to three participants, and to see the pathophysiology of disease in a more comprehensive anatomical context. Further, the Vega imaging system enables us to overcome difficulties with traditional hand-held ultrasound systems and generates findings that are more constant as compared to conventional ultrasound systems.
  • FUJIFILM VisualSonics Inc. launched Vevo F2, which includes HD image processing to provide clearer images and substantially higher frame rates than platforms from preceding generations.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5231
  • Published Date: Sep 15, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of cancer across the globe and the rising trend of precision medicine are the major factors driving the growth of the market.

The market size of In-vivo Imaging is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024 – 2036.

The major players in the market are Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions.

The Micro-MRI segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
In-vivo Imaging Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying